0 followers
Anchored by our protein-engineering expertise and our proprietary single-domain antibody platform, we’ve developed a unique pipeline of therapeutic candidates.
Mark P. Lappe
Halozyme Therapeutics
5 followers
REVOLUTION Medicines
5 followers
Kymera Therapeutics
5 followers
C4 Therapeutics
4 followers
Stemline Therapeutics
3 followers
Inari
3 followers
Prelude Therapeutics
3 followers
Active Motif
3 followers
Pivot Bio
2 followers
Vor Biopharma
2 followers
Generation Bio
2 followers
Explore companies